Skip to main content

Table 2 Quality assessment criteria

From: A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease

  3 2 1 0
Patients at baseline, number >151 101 to 150 51 to 100 <50
Follow-up time, years >3 or mean ≥ 3 2
Clinical criteria Established criteria for AD + DLB criteria from 2005 Established criteria for AD + DLB criteria from 1992 or 1996 Used criteria for one type of dementia No criteria used
Autopsy, % of participants 100 >50 >25 None
  1. AD, Alzheimer’s disease; DLB, dementia with Lewy bodies; BNT, Boston naming test; CERAD, Consortium to Establish a Registry for Alzheimer’s Disease evaluation; DRS, dementia rating scale; ESD, extended scale for dementia; HVLT-R Hopkins verbal learning test-revised; mMMS, modified mini-mental state examination; MMSE, mini mental state examination; MTS, 37 item mental test score.